Phenotype-genotype correlations and the efficacy of growth hormone treatment in Korean children with Prader-Willi syndrome.
10.3345/kjp.2008.51.3.315
- Author:
Keun Wook BAE
1
;
Jung Min KO
;
Han Wook YOO
Author Information
1. Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Prader-Willi syndrome;
Phenotype-genotype correlation;
Microdeletion;
Uniparental disomy;
Growth hormone
- MeSH:
Birth Weight;
Body Mass Index;
Child;
Chromosomes, Human, Pair 15;
Cryptorchidism;
Cytogenetic Analysis;
Genotype;
Growth Hormone;
Humans;
Hypopigmentation;
Intellectual Disability;
Male;
Maternal Age;
Medical Records;
Phenotype;
Prader-Willi Syndrome;
Retrospective Studies;
Uniparental Disomy
- From:Korean Journal of Pediatrics
2008;51(3):315-322
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Prader-Willi syndrome (PWS) is a complex genetic disorder, caused by the deletion of the paternally derived 15q11-13 region or the maternal uniparental disomy of chromosome 15 (mUPD(15)). In this study, we compared phenotypic differences between those patients whose disease was caused by microdeletion and those caused by mUPD(15). In addition, a comparison of the efficacy of growth hormone (GH) therapy between these two PWS genotypes was analyzed. METHODS: Fifty-three patients were diagnosed as having PWS based on molecular and cytogenetic analyses and clinical features. Data that included maternal age, birth weight, a feeding problem in the neonatal period, cryptorchidism, developmental delay or mental retardation, short stature, hypopigmentation, changes in height, weight, and body mass indexes (BMI) before and after GH treatment were obtained by a retrospective review of medical records. The data from the patients with microdeletion were compared with those from the patients with mUPD(15). RESULTS: Of the 53 patients with genetically confirmed PWS, 39 cases had microdeletion and 14 mUPD(15). Maternal ages were significantly higher in the mUPD(15) group, and hypopigmentation and a feeding problem in the neonatal period were more frequent in the microdeletion group. Growth hormone was administered to 20 patients [14 with microdeletion, 6 with mUPD(15)]. There were no differences between the two groups in height velocity, weight and height SDS, and BMI after GH therapy. CONCLUSION: Phenotype and genotype correlations were observed in Korean PWS patients, such as more advanced maternal ages in the mUPD(15) group and more feeding problems and hypopigmentations in the microdeletion group. Further long-term prospective studies are needed to correlate other aspects of the phenotypes.
